Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide.
The latest update on Synthomer centres on a higher fair value estimate, moving from £1.27 to £1.47 in the refreshed model. Street commentary has turned more constructive, with raised price targets in GBp terms broadly aligned with this shift, even as many ratings remain in the neutral camp. As you read on, you will see how this evolving analyst narrative might shape your view on Synthomer and what to watch as the story continues to develop.
Stay updated as the Fair Value for Synthomer shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Synthomer.
What Wall Street Has Been Saying
🐂 Bullish Takeaways
-
For Synthomer, Deutsche Bank has lifted its price target to 92 GBp from 62 GBp, which lines up with a more constructive stance on the stock's valuation, even while keeping a Hold rating.
-
The higher targets from Deutsche Bank and Berenberg point to some renewed confidence that Synthomer's execution and balance of risks are better reflected in current models than before.
🐻 Bearish Takeaways
-
Despite the upward revision to 92 GBp, Deutsche Bank's decision to maintain a Hold rating signals that the firm still sees limitations to the upside at today's levels.
-
The neutral ratings attached to these price target moves suggest that, while analysts acknowledge potential in Synthomer, they also see ongoing questions around how quickly growth prospects and operational delivery may improve.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives!
We've flagged 2 risks for Synthomer. See which could impact your investment.
How This Changes the Fair Value For Synthomer
-
Fair Value has risen from £1.27 to £1.47 in the updated model.
-
Revenue Growth assumption has been reset from 0.07% to 5.31%.
-
Net Profit Margin has moved from 10.35% to 9.99%.
-
Future P/E has increased from 1.54x to 1.72x.
-
Discount Rate has moved from 13.21% to 13.39%.
Never Miss an Update: Follow The Narrative
Narratives link Synthomer's business story to the financial assumptions behind its fair value. They update as new data, forecasts and risks emerge. This helps you see how individual news items fit into the bigger picture for the company.
Head over to the Simply Wall St Community and follow the Narrative on Synthomer to stay up to date on:
-
How Synthomer's shift toward higher value specialty polymers, cost reduction and portfolio simplification aims to support more resilient margins and earnings quality.
-
The role of eco friendly and bio based polymers, certifications such as ISCC+ and partnerships like Henkel in shaping new product launches and higher margin revenue streams.
-
Key constraints including high leverage, European market exposure, industry overcapacity, sustainability pressures on petrochemical products and raw material or geopolitical risks.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SYNT.L .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
